Abstract
The effect of BCNU, bleomycin, chloramphenicol, cisplatin, dicoumarol, disulfiram, ketogenic diet, pindolol, propoxyphene, teniposide, thioridazine, tipranavir/ritonavir, troleandomycin and vinblastine on the pharmacokinetics of phenobarbital are described. Also, potential pharmacodynamic interactions are highlighted.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Grossman SA, Sheidler VR, Gilbert MR. Decreased phenytoin levels in patients receiving chemotherapy. Am J Med. 1989;87:505–10.
Fincham RW, Schottelius DD. Decreased phenytoin levels in antineoplastic therapy. Ther Drug Monit. 1979;1:277–83.
Koup JR. Interaction of chloramphenicol with phenytoin and phenobarbital. A case report. Clin Pharmacol Ther. 1978;24:393–402.
Cucinell SA, Conney AH, Sansur MS, Burns JJ. Drug interactions in man. I. Lowering effect of phenobarbital on plasma levels of bishydroxycoumarin (Dicoumarol®) and diphenylhydantoin (Dilantin®). Clin Pharmacol Ther. 1965;6:420–9.
Olesen OV. The influence of disulfiram and calcium carbimide on the serum diphenylhydantoin. Excretion of HPPH in the urine. Arch Neurol. 1967;16:642–4.
Coppola G, Verrotti A, D’Aniello A, Arcieri S, Operto FF, Della Conte R, Ammendola E, Pascotto A. Valproic acid and phenobarbital blood levels during the first month of treatment with the ketogenic diet. Acta Neurol Scand. 2010;122:303–7.
Greendyke RM, Gulya A. Effect of pindolol administration on serum levels of thioridazine, haloperidol, phenytoin, and phenobarbital. J Clin Psychiatry. 1988;49:105–7.
Hansen SB, Dam M, Brandt J, Hvidberg EF, Angelo H, Christensen MJ, Lous P. Influence of dextropropoxyphene on steady state serum levels and protein binding of three anti-epileptic drugs in man. Acta Neurol Scand. 1980;61:357–67.
Baker DK, Relling MV, Pui CH, Christensen ML, Evans WE, Rodman JH. Increased teniposide clearance with concomitant anticonvulsant therapy. J Clin Oncol. 1992;10:311–5.
Gay PE, Madsen JA. Interaction between phenobarbital and thioridazine. Neurology. 1983;33:1631–2.
Bonaro S, Calgagno A, Fontana S, D’Avolio A, Siccardi M, Gobbi F, Di Perri G. Clinically significant interaction between tipranavir ritonavir and phenobarbital in an HIV-infected patient. Clin Infect Dis. 2007;45:1654–5.
Dravet C, Mesdjian E, Cenraud B, Roger J. Interaction between carbamazepine and triacetyloleandomycin. Lancet. 1997;1:810–1.
Bollini P, Riva R, Albani F, Ida N, Cacciari L, Bollini C, Baruzzi A. Decreased phenytoin level during antineoplastic therapy: a case report. Epilepsia. 1983;24:75–8.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Patsalos, P.N. (2016). Phenobarbital. In: Antiepileptic Drug Interactions. Springer, Cham. https://doi.org/10.1007/978-3-319-32909-3_45
Download citation
DOI: https://doi.org/10.1007/978-3-319-32909-3_45
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32908-6
Online ISBN: 978-3-319-32909-3
eBook Packages: MedicineMedicine (R0)